Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years

[1]  D. Palmer,et al.  Rheumatoid arthritis: recommendations for treat to target. , 2014, British journal of nursing.

[2]  M. Arnold,et al.  Barriers to Optimal Disease Control for Rheumatoid Arthritis Patients With Moderate and High Disease Activity , 2014, Arthritis care & research.

[3]  M. Wiese,et al.  Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis , 2014, The Pharmacogenomics Journal.

[4]  Jonathan Kay,et al.  Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) , 2013, Annals of the rheumatic diseases.

[5]  A. J. van der Beek,et al.  The relation between body mass index and musculoskeletal symptoms in the working population , 2013, BMC Musculoskeletal Disorders.

[6]  H. H. Kuper,et al.  Sustained Beneficial Effects of a Protocolized Treat‐to‐Target Strategy in Very Early Rheumatoid Arthritis: Three‐Year Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort , 2013, Arthritis care & research.

[7]  H. H. Kuper,et al.  Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort , 2012, Arthritis Research & Therapy.

[8]  D. Symmons,et al.  Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritis , 2012, Arthritis care & research.

[9]  C. V. D. van den Ende,et al.  Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature , 2012, Expert review of clinical immunology.

[10]  H. H. Kuper,et al.  A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry , 2011, Annals of the rheumatic diseases.

[11]  H. H. Kuper,et al.  Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. , 2011, Arthritis and rheumatism.

[12]  L. Fraenkel,et al.  Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment , 2011, Arthritis care & research.

[13]  C. Zimmer,et al.  The role of helplessness, outcome expectation for exercise and literacy in predicting disability and symptoms in older adults with arthritis. , 2010, Patient education and counseling.

[14]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[15]  D. Atar,et al.  ‘Treat to target’: moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[16]  Maurizio Cutolo,et al.  Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.

[17]  J. Smolen,et al.  Impact of comorbidity on physical function in patients with rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[18]  P. Helliwell,et al.  The Composite DAS Score is Impractical to use in Daily Practice: Evidence That Physicians use the Objective Component of the DAS in Decision Making , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[19]  M. Dougados,et al.  Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate , 2008, Annals of the rheumatic diseases.

[20]  R. Kaiser.  Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature. , 2008, Clinical lymphoma & myeloma.

[21]  W. Taylor,et al.  Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement. , 2007, Rheumatology.

[22]  C. Hill,et al.  Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. , 2007, Seminars in arthritis and rheumatism.

[23]  F. Wolfe,et al.  Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. , 2007, Arthritis and rheumatism.

[24]  聡美 古田.  VAS（Visual Analogue Scale）を用いた高校生の月経随伴症状の評価 , 2006 .

[25]  Vahram Ghushchyan,et al.  Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. , 2005, Diabetes care.

[26]  A. McMahon,et al.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial , 2004, The Lancet.

[27]  J. Smolen,et al.  Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[28]  K. Pile,et al.  Disease modifying drugs in adult rheumatoid arthritis , 2003 .

[29]  J. Smolen,et al.  Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. , 2002, The Journal of rheumatology.

[30]  P. Shekelle,et al.  How to read radiographs according to the Sharp/van der Heijde method. , 1999 .

[31]  D. V. D. Heijde,et al.  The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. , 1997, British journal of rheumatology.

[32]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[33]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[34]  S. Soraci,et al.  Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. , 1983, Arthritis and rheumatism.

[35]  T. Pincus.  Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? , 2010, Bulletin of the NYU hospital for joint diseases.

[36]  R. Devellis,et al.  A brief measure of helplessness in rheumatic disease: the helplessness subscale of the Rheumatology Attitudes Index. , 1993, The Journal of rheumatology.

[37]  K. Wallston,et al.  The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index. , 1985, The Journal of rheumatology.

[38]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.